Cargando…
Drug Delivery Technology to the CNS in the Treatment of Brain Tumors: The Sherbrooke Experience
Drug delivery to the central nervous system (CNS) remains a challenge in neuro-oncology. Despite decades of research in this field, no consensus has emerged as to the best approach to tackle this physiological limitation. Moreover, the relevance of doing so is still sometimes questioned in the commu...
Autor principal: | Fortin, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571772/ https://www.ncbi.nlm.nih.gov/pubmed/31137918 http://dx.doi.org/10.3390/pharmaceutics11050248 |
Ejemplares similares
-
Struggling for breath in Sherbrooke - 1st Symposium on “One mitochondrion, many diseases” in Sherbrooke, Québec, Canada, March 11th, 2015
por: Braun, Ralf J., et al.
Publicado: (2015) -
Management of Primary Central Nervous System Lymphoma Using Intra-Arterial Chemotherapy With Osmotic Blood-Brain Barrier Disruption: Retrospective Analysis of the Sherbrooke Cohort
por: Iorio-Morin, Christian, et al.
Publicado: (2021) -
Case-finding for disabilities with PRISMA-7 in emergency rooms: evolution in Sherbrooke, Québec
por: Raîche, Michel, et al.
Publicado: (2009) -
Lomustine’s nanoemulsion as nose-to-brain drug delivery system for CNS tumor treatment
por: Alaayedi, Maryam H., et al.
Publicado: (2023) -
Perispinal Delivery of CNS Drugs
por: Tobinick, Edward Lewis
Publicado: (2016)